Role of open lymph node biopsy in node-negative penile cancer

Answer generated by Itaca · 5 sources · February 20, 2025

Original question

Find research article supporting the role of open lymph node biopsy for clinically node negative groin in carcinoma of penis

Summary

In managing penile cancer, particularly for clinically node-negative (cN0) patients, the role of lymph node biopsies is crucial. While dynamic sentinel lymph node biopsy (DSNB) is increasingly recommended due to its minimally invasive nature and lower morbidity compared to traditional open lymph node dissections, there is still a place for open lymph node biopsy in specific scenarios. Open lymph node biopsy, such as modified inguinal lymph node dissection (mILND), is often considered for high-risk patients or when DSNB is not feasible. This approach aims to balance oncological outcomes with reduced morbidity.

Role of Open Lymph Node Biopsy

Open lymph node biopsy, specifically modified inguinal lymph node dissection (mILND), remains a viable option for managing penile cancer, especially in high-risk cases or when sentinel lymph node biopsy is not available or feasible. mILND is less morbid than radical inguinal lymphadenectomy but still provides effective staging and treatment of lymph node metastases[1].

Clinical Indications

  • High-Risk Patients: For patients with high-risk penile cancer (e.g., pT1b or greater, or presence of lymphovascular invasion), mILND is recommended alongside DSNB as an alternative for invasive lymph node staging[1][2].
  • Non-Palpable Nodes: In cases where inguinal nodes are non-palpable (cN0), both DSNB and mILND are considered for accurate staging to detect occult metastases[3][2].

Comparison with DSNB

  • Morbidity: DSNB offers lower morbidity compared to open dissections like mILND, reducing complications such as lymphedema and wound infections[2].
  • Sensitivity and False-Negative Rates: DSNB has a reported sensitivity of about 88% and a false-negative rate that can be as low as 4.8% with optimized techniques[1][2]. However, mILND may provide more comprehensive lymph node removal, potentially reducing false negatives.

Clinical Decision-Making

The choice between DSNB and open lymph node biopsy depends on several factors, including the patient's risk profile, availability of expertise, and institutional preferences. Current guidelines from organizations like the European Association of Urology recommend both methods for cN0 patients with intermediate to high-risk tumors[2].

Scientific Evidence

Several studies support the use of both DSNB and mILND in penile cancer management:

  • A study by Spiess et al. demonstrated no recurrences in patients undergoing mILND without metastatic disease found, highlighting its effectiveness in selected cases[1].
  • The European Association of Urology guidelines endorse both DSNB and mILND for staging in cN0 patients with intermediate to high-risk tumors[2].

Health Impact

The management of lymph nodes in penile cancer significantly impacts patient outcomes. Early detection and treatment of lymph node metastases can improve survival rates, with 5-year survival rates varying significantly based on lymph node involvement[1][2]. Therefore, choosing the appropriate lymph node staging method is critical for optimizing patient care.

Sources

  1. https://tau.amegroups.org/article/view/29112/html
  2. https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.850905/full
  3. https://tau.amegroups.org/article/view/126572/html
  4. https://www.tandfonline.com/doi/full/10.1586/14737140.6.7.963
  5. https://www.mdpi.com/2072-6694/16/17/2935

AI-generated answer based on the cited sources. Check the sources before applying it.

Have a question about your own case? Itaca answers with sources in seconds.

Ask a question